Literature DB >> 3495285

Experimental Pneumocystis carinii pneumonia in the ferret.

D C Stokes, F Gigliotti, J E Rehg, R L Snellgrove, W T Hughes.   

Abstract

Pneumocystis carinii pneumonia (PCP) was provoked in the ferret, Mustela pulorius furo, by immunosuppression with daily long-term administration of cortisone acetate, 10-20 mg/kg subcutaneously for 9 to 10 weeks, Microscopically P. carinii was observed in the lungs of all 11 treated animals: mild to moderate in five and extensive disease in six. The histopathological features of PCP in the ferret included interstitial pneumonitis, scant mononuclear cell alveolitis, with abundant cysts and trophozoites visible in a focal distribution. There were few neutrophils present. Electron microscopy showed large numbers of both cysts and trophozoites in close association with type I cells. No bacterial pathogens were isolated from the lungs of immunosuppressed animals but an unexplained eosinophilic enteritis was present in treated animals. P carinii pneumonia developed without significant body weight loss during corticosteroid administration, unlike previously described studies using corticosteroid-treated rodents. Ferrets thus appear to be a 'steroid resistant' animal, like man, and therefore a more suitable model for immunological studies of host response to PCP than rodents. This new model also has practical advantages over previously described animal models of PCP, including larger lung and airway size.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495285      PMCID: PMC2013017     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  16 in total

1.  Corticosteroids and lymphoid cells.

Authors:  H N Claman
Journal:  N Engl J Med       Date:  1972-08-24       Impact factor: 91.245

2.  Basic and 'special' stains for plastic sections in bone marrow histopathology, with special reference to May-Grünwald Giemsa and enzyme histochemistry.

Authors:  P Bianco; A Ponzi; E Bonucci
Journal:  Basic Appl Histochem       Date:  1984

3.  Clinical relevance of animal models of Pneumocystis carinii pneumonia.

Authors:  P D Walzer; L S Young
Journal:  Diagn Microbiol Infect Dis       Date:  1984-01       Impact factor: 2.803

4.  Provocation of infection due to Pneumocystis carinii by cyclosporin A.

Authors:  W T Hughes; B Smith
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

5.  Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; R D Powell; K Yoneda; M E Rutledge; J E Milder
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

6.  Protein-calorie malnutrition. A host determinant for Pneumocystis carinii infection.

Authors:  W T Hughes; R A Price; F Sisko; W S Havron; A G Kafatos; M Schonland; P M Smythe
Journal:  Am J Dis Child       Date:  1974-07

7.  Interaction of Pneumocystis carinii with host lungs: an ultrastructural study.

Authors:  K Yoneda; P D Walzer
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

8.  Natural mode of acquisition for de novo infection with Pneumocystis carinii.

Authors:  W T Hughes
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

9.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.

Authors:  M S Gottlieb; R Schroff; H M Schanker; J D Weisman; P T Fan; R A Wolf; A Saxon
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

10.  Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; P C McNabb; T D Makres; S Feldman
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

View more
  7 in total

1.  Pneumocystis melanins confer enhanced organism viability.

Authors:  Crystal R Icenhour; Theodore J Kottom; Andrew H Limper
Journal:  Eukaryot Cell       Date:  2006-06

Review 2.  Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model.

Authors:  Adélaïde Chesnay; Christophe Paget; Nathalie Heuzé-Vourc'h; Thomas Baranek; Guillaume Desoubeaux
Journal:  J Fungi (Basel)       Date:  2022-01-27

3.  Induction of fibrinogen expression in the lung epithelium during Pneumocystis carinii pneumonia.

Authors:  P J Simpson-Haidaris; M A Courtney; T W Wright; R Goss; A Harmsen; F Gigliotti
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

4.  Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models.

Authors:  F Gigliotti; W T Hughes
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

5.  Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses.

Authors:  W Chen; J W Mills; A G Harmsen
Journal:  Int J Exp Pathol       Date:  1992-12       Impact factor: 1.925

6.  Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice.

Authors:  P D Walzer; C K Kim; M J Linke; C L Pogue; M J Huerkamp; C E Chrisp; A V Lerro; S K Wixson; E Hall; L D Shultz
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

7.  Latency is not an inevitable outcome of infection with Pneumocystis carinii.

Authors:  W Chen; F Gigliotti; A G Harmsen
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.